• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Editor’s Choice

Editor's Choice

Health for Life Capital II™, World Leading Microbiome-focused Fund Announces its First Close

March 5, 2019 Microbiome Times

Seventure Partners, one of Europe’s leaders in financing innovation and a world-leader in life science microbiome investment, announces it has completed the first closing of its second dedicated fund focused on the microbiome, and health, […]

Editor's Choice

Here’s What Happened at Probiota, 13-15 February in Copenhagen

March 1, 2019 Nina Vinot

Probiota Copenhagen 2019 broke a new record, going from 250 attendees last year to 350 and sold out! Why? Because of its unique approach to bringing together stakeholders from the industry, the academy, CROs and […]

Editor's Choice

Jeffrey Gordon wins the Frontiers of Knowledge Award for pioneering microbiome research

February 14, 2019 Microbiome Times

The BBVA Foundation Frontiers of Knowledge Award in the Biology and Biomedicine category has gone in this eleventh edition to American researcher Jeffrey Gordon, for his fundamental discovery of the importance of the gut microbial […]

Editor's Choice

More than 100 new gut bacteria discovered in human microbiome

February 8, 2019 Microbiome Times

Scientists working on the gut microbiome* have discovered and isolated more than 100 completely new species of bacteria from healthy people’s intestines. The study from the Wellcome Sanger Institute, Hudson Institute of Medical Research, Australia, […]

Editor's Choice

Modelling Holobiont Evolution for a Better Understanding of Symbiosis, Dysbiosis, and Human Health

February 3, 2019 Kristina Campbell

The list of presentations from any recent microbiome conference shows the diversity of approaches by which scientists are pursuing discovery of microbiome-focused therapeutics. And common to all of these approaches is the essential need to […]

Editor's Choice

Biotech Focus: An Interview with Ken Blount, CSO, Rebiotix

January 7, 2019 Microbiome Times

In just a few short years, Rebiotix has taken the concept of “bugs as drugs” and turned it into actual practice, constructing a standardized, stabilized drug product from the broad consortia of microbes present in a […]

Editor's Choice

EMA Rules On Omega-3 Medicinal Products – Useful Parallels for the Pharmabiotics Industry

December 21, 2018 Dr. Magali Cordaillat-Simmons (PhD)

On 13 December 2018, the European Medicines Agency (EMA) released the following statement: “Omega-3 fatty acid medicines are no longer considered as effective in preventing heart disease.” As several communications have been published by multiple […]

Editor's Choice

Pharmabiotics Young Investigator Awards: Supporting Tomorrow’s Microbiome Opinion Leaders

November 22, 2018 Microbiome Times

The successful introduction of the 2018 Pharmabiotics Young Investigator Awards set the stage for its development as one of the most important and prestigious awards for young microbiome researchers.  Co-initiated by the Pharmabiotic Research Institute […]

Editor's Choice

6th Microbiome R&D and Business Collaboration Forum USA Summary

November 20, 2018 Anusha Gandhi

This summary of the 6th R&D and Business Collaboration Forum was authored by Anusha Gandhi from Microbiome Insights. The original version can be found here on their blog Leaders in the microbiome industry met in San […]

Editor's Choice

Researchers Identify Three Distinct Stages in Infant Microbiome Development

October 26, 2018 Microbiome Times

In the largest clinical microbiome study in infants reported to date, a team led by researchers at Baylor College of Medicine explored the sequence of microbial colonization in the infant gut through age 4 and […]

Editor's Choice

Reading Between the Lines: What the FDA Public Workshop Really Tells Us About the Regulation of Microbiome-Based Products

October 3, 2018 Dr. Magali Cordaillat-Simmons (PhD)

On September 17, 2018 hopes were high regarding the clarification of the regulatory framework as well as a potential decision or ambitions by the FDA to stimulate further discussion regarding microbiome-based products, as the agency […]

Posts navigation

« 1 … 12 13 14 »

Sign Up to Free Newsletter

QIAGEN WEBINAR SERIES – REGISTER HERE

NEW WHITEPAPER: ORAL DELIVERY OF LIVE BIOTHERAPEUTIC PRODUCTS:

Editor’s Choice

  • LACTIN-V: A Promising Live Biotherapeutic for Recurrent Bacterial Vaginosis
    May 1, 2026
  • Lactic Acid’s Untapped Potential to Optimise the Vaginal Microbiota and Mucosal Environment
    April 8, 2026
  • Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence
    March 24, 2026
  • Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis
    February 11, 2026
  • Immunity as a Lifestyle Priority
    January 30, 2026
sign up

Sign up to the Microbiome Times newsletter